Oppenheimer & Co. 29th Annual Healthcare Conference
Westin Grand Central Hotel - 212 East 42nd St, New York City
Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T
New York City
NobleConXV - Noble Capital Markets' Fifteenth Annual Investor Conference
W Hotel, Fort Lauderdale, Florida | Studio 4
Biotech Showcase™ 2019
Hilton San Francisco Union Square, San Francisco, CA
30th Annual Piper Jaffray Healthcare Conference
Lotte New York Palace Hotel, New York, NY
BIO-Europe® 24th Annual International Partnering Conference
Bella Center Copenhagen, Copenhagen, Denmark - Room B2 on level 0
Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease
The Langham Hotel, New York, NY
Maxim Rights Offering Conference
New York, NY
2018 B. Riley FBR Healthcare Conference
New York Marriott East Side, New York, NY - Stuyvesant Room
Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients Webcast
19th Annual Bio€quity Europe Conference
Het Pand Convention Center, Ghent, Belgium
American Association for Cancer Research Annual Meeting (AACR)
Chicago, IL
28th Annual Oppenheimer Healthcare Conference
The Westin New York Grand Central, New York, NY
30th Annual ROTH Conference
The Ritz Carlton, Laguna Niguel, Dana Point, CA
BIO CEO & Investor Conference
New York Marriott Marquis, 1535 Broadway, New York, NY 10036
Biotech Showcase™ 2018
Hilton San Francisco Union Square, San Francisco, CA
2017 Annual Meeting of Stockholders
The Garden City Hotel - Garden City, NY
Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz
BIO Investor Forum
Westin St. Francis Horel, San Francisco, CA
Rodman & Renshaw 19th Annual Global Investment Conference
Lotte New York Palace Hotel, New York, NY
4th Annual Summit on Hematologic Malignancies
Fairmont Chateau Whistler, British Columbia, Canada
29th Annual ROTH Conference
The Ritz-Carlton Laguna Niguel, Dana Point, CA
Source Capital Group’s 2017 Disruptive Growth & Healthcare Conference
Track 1 – Tribeca Room, the Convene, New York, New York
Ladenburg Thalmann 2nd Annual Healthcare Conference
Sofitel Hotel, New York, NY
Actimab-A Phase 2 Clinical Trial Update
Rodman & Renshaw 18th Annual Global Investment Conference
Lotte New York Palace Hotel, New York, NY
BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference
Millenium Broadway Hotel & Conference Center, New York, NY
2016 BIO International Convention
Theater #1, 2nd Floor, West Exhibit Hall, Moscone Center, San Francisco, CA
2016 BIO International Convention
Theater #1, 2nd Floor, West Exhibit Hall, Moscone Center, San Francisco, CA
Actimab-A Phase 1 Trial Results and Key Findings from the HuM195-Alpha Program
Joseph Jurcic, MD, Director of Hematologic Malignancies; Professor of Clinical Medicine Columbia University Medical Center. Principal Investigator
David Scheinberg, MD, PhD, Chair of Experimental Therapeutics Center; Chair of Molecular Pharmacology & Chemistry Program Memorial Sloan Kettering Cancer Center. Scientific Co-Founder
Sandesh Seth, Executive Chairman, Actinium Pharmaceuticals, Inc.
Dragan Cicic, MD, Chief Medical Officer, Actinium Pharmaceuticals, Inc.